407 related articles for article (PubMed ID: 25367038)
1. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
[TBL] [Abstract][Full Text] [Related]
2. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
4. Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex.
Ramia NF; Spilman M; Tang L; Shao Y; Elmore J; Hale C; Cocozaki A; Bhattacharya N; Terns RM; Terns MP; Li H; Stagg SM
Cell Rep; 2014 Dec; 9(5):1610-1617. PubMed ID: 25482566
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray diffraction analysis of the CRISPR-Cas RNA-silencing Cmr complex.
Osawa T; Inanaga H; Numata T
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):735-40. PubMed ID: 26057804
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
Osawa T; Inanaga H; Numata T
J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
[TBL] [Abstract][Full Text] [Related]
7. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
Zhu X; Ye K
Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
[TBL] [Abstract][Full Text] [Related]
8. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex.
Shao Y; Cocozaki AI; Ramia NF; Terns RM; Terns MP; Li H
Structure; 2013 Mar; 21(3):376-84. PubMed ID: 23395183
[TBL] [Abstract][Full Text] [Related]
10. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.
Staals RHJ; Agari Y; Maki-Yonekura S; Zhu Y; Taylor DW; van Duijn E; Barendregt A; Vlot M; Koehorst JJ; Sakamoto K; Masuda A; Dohmae N; Schaap PJ; Doudna JA; Heck AJR; Yonekura K; van der Oost J; Shinkai A
Mol Cell; 2013 Oct; 52(1):135-145. PubMed ID: 24119403
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Cmr2 suggests a nucleotide cyclase-related enzyme in type III CRISPR-Cas systems.
Zhu X; Ye K
FEBS Lett; 2012 Mar; 586(6):939-45. PubMed ID: 22449983
[TBL] [Abstract][Full Text] [Related]
12. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.
Hale CR; Majumdar S; Elmore J; Pfister N; Compton M; Olson S; Resch AM; Glover CV; Graveley BR; Terns RM; Terns MP
Mol Cell; 2012 Feb; 45(3):292-302. PubMed ID: 22227116
[TBL] [Abstract][Full Text] [Related]
13. Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4.
Benda C; Ebert J; Scheltema RA; Schiller HB; Baumgärtner M; Bonneau F; Mann M; Conti E
Mol Cell; 2014 Oct; 56(1):43-54. PubMed ID: 25280103
[TBL] [Abstract][Full Text] [Related]
14. The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.
Terns RM; Terns MP
Biochem Soc Trans; 2013 Dec; 41(6):1416-21. PubMed ID: 24256230
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure and CRISPR RNA-binding site of the Cmr1 subunit of the Cmr interference complex.
Sun J; Jeon JH; Shin M; Shin HC; Oh BH; Kim JS
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):535-43. PubMed ID: 24531487
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
17. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
[TBL] [Abstract][Full Text] [Related]
18. Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.
Sofos N; Feng M; Stella S; Pape T; Fuglsang A; Lin J; Huang Q; Li Y; She Q; Montoya G
Mol Cell; 2020 Sep; 79(5):741-757.e7. PubMed ID: 32730741
[TBL] [Abstract][Full Text] [Related]
19. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
[TBL] [Abstract][Full Text] [Related]
20. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.
Staals RH; Zhu Y; Taylor DW; Kornfeld JE; Sharma K; Barendregt A; Koehorst JJ; Vlot M; Neupane N; Varossieau K; Sakamoto K; Suzuki T; Dohmae N; Yokoyama S; Schaap PJ; Urlaub H; Heck AJ; Nogales E; Doudna JA; Shinkai A; van der Oost J
Mol Cell; 2014 Nov; 56(4):518-30. PubMed ID: 25457165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
